Starfire Investment Advisers’s AbbVie ABBV Stock Holding History

Starfire Investment Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$670K	Buy	6,830 +53	+0.8%	+$4.67K	0.32%	77
2020 Q1	$516K	Sell	6,777 -673	-9%	-$57.3K	0.28%	85
2019 Q4	$659K	Buy	7,450 +200	+3%	+$16.6K	0.25%	86
2019 Q3	$549K	Buy	7,250 +221	+3%	+$15.2K	0.23%	95
2019 Q2	$511K	Hold	7,029	–	–	0.23%	92
2019 Q1	$566K	Hold	7,029	–	–	0.26%	88
2018 Q4	$648K	Buy	7,029 +3,022	+75%	+$266K	0.35%	69
2018 Q3	$378K	Sell	4,007 -3,022	-43%	-$287K	0.19%	90
2018 Q2	$651K	Hold	7,029	–	–	0.33%	69
2018 Q1	$665K	Buy	+7,029	New	+$772K	0.35%	70
2017 Q4	–	Sell	-4,157	Closed	-$369K	–	149
2017 Q3	$369K	Hold	4,157	–	–	0.22%	84
2017 Q2	$301K	Hold	4,157	–	–	0.18%	101
2017 Q1	$268K	Hold	4,157	–	–	0.14%	114
2016 Q4	$260K	Hold	4,157	–	–	0.15%	115
2016 Q3	$262K	Hold	4,157	–	–	0.16%	117
2016 Q2	$257K	Buy	4,157 +6	+0.1%	+$366	0.18%	108
2016 Q1	$237K	Buy	4,151 +7	+0.2%	+$390	0.16%	115
2015 Q4	$246K	Buy	4,144 +5	+0.1%	+$288	0.17%	114
2015 Q3	$225K	Buy	4,139 +4	+0.1%	+$260	0.16%	117
2015 Q2	$278K	Buy	4,135 +5	+0.1%	+$326	0.18%	107
2015 Q1	$242K	Buy	+4,130	New	+$250K	0.16%	116

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Starfire Investment Advisers's ABBV Position: Q2 2020 in Review

Starfire Investment Advisers increased its AbbVie (ABBV) stake by 0.78% in Q2 2020, buying an estimated $4.67K and bringing the position to 6,830 shares worth $670K. The position accounts for 0.32% of the portfolio, ranked #77.

Starfire Investment Advisers first reported a position in ABBV in Q1 2015 and has held it in 21 quarters since. 2,411 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

Starfire Investment Advisers held 6,830 shares of AbbVie worth $670K as of Q2 2020.
Starfire Investment Advisers bought 53 AbbVie shares in Q2 2020, an estimated $4.67K.
AbbVie made up 0.32% of Starfire Investment Advisers's portfolio in Q2 2020, its #77 holding.
Starfire Investment Advisers first reported a position in AbbVie in Q1 2015 and has held it in 21 quarters since.
2,411 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Starfire Investment Advisers's 13F filing for Q2 2020, filed 9 Jul 2020.